注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Capricor Therapeutics Inc是一家生物技術公司。該公司專注於開發基於轉化細胞和外質體的療法和疫苗,用於治療和預防廣泛的疾病。該公司由細胞治療計劃組成,包括針對杜氏肌營養不良症的CAP-1002計劃和針對冠狀病毒(COVID-19)的CAP-1002和CAP-1002計劃。該公司的主要候選藥物CAP-1002是一種異基因心臟衍生細胞療法。CAP-1002正在臨床開發中,用於治療Duchenne肌營養不良症和與2019冠狀病毒疾病相關的細胞因子風暴。Capricor也在開發其exosome技術治療平台。該公司致力於開發能夠輸送核酸(包括信使RNA(mRNA)和蛋白質)的外顯體,以治療或預防一系列疾病。CAP-1002細胞治療項目啟動了關鍵的第三階段HOPE-3。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Frank Isaac Litvack | 67 | 2012 | Executive Chairman of the Board |
Linda Marbán | 60 | 2010 | Co-Founder, President, CEO & Director |
Eduardo Marbán | - | - | Co-Founder & Chairman of Scientific Advisory Board |
Oscar Henry Mayer | - | - | Member of Scientific Advisory Board |
Barry J. Byrne | - | - | Member of Scientific Advisory Board |
Thomas Voit | - | - | Member of Scientific Advisory Board |
Eugenio Mercuri | - | - | Member of Scientific Advisory Board |
Earl M. Collier | 77 | 2013 | Independent Director |
David Brian Musket | 66 | 2013 | Independent Director |
Francesco Muntoni | - | - | Member of Scientific Advisory Board |
George W. Dunbar | 77 | 2013 | Independent Director |
Craig McDonald | - | - | Member of Scientific Advisory Board |
Michelle Eagle | - | - | Member of Scientific Advisory Board |
Pat Furlong | - | - | Member of Scientific Advisory Board |
Philip J. Gotwals | 61 | 2023 | Independent Director |
Paul Gisbert Auwaerter | 62 | 2023 | Independent Director |
Karimah Es Sabar | 66 | 2021 | Independent Director |
Michael Kelliher | 47 | 2023 | Independent Director |
Timothy R. Franson | 72 | 2023 | Member of the Scientific Advisory Board |
Michael Taylor | - | 2018 | Member of Scientific Advisory Board |
Suzanne Hendrix | - | 2023 | Member of Scientific Advisory Board |
Chet Villa | - | 2023 | Member of the Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核